Log In
BCIQ
Print this Print this
 

Calcium aluminosilicate anti-diarrheal

  Manage Alerts
Collapse Summary General Information
Company Salient Pharmaceuticals Inc.
Description 
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDiarrhea (non-infectious)
Indication DetailsTreat cancer therapy-induced diarrhea
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today